17 results
DRS/A
EX-10.25
VIR
Vir Biotechnology Inc
7 Aug 19
Draft registration statement (amended)
12:00am
Policy
The Bill & Melinda Gates Foundation is committed to information sharing and transparency. We believe that published research resulting from
S-1
EX-10.25
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
Policy
The Bill & Melinda Gates Foundation is committed to information sharing and transparency. We believe that published research resulting from
424B4
VIR
Vir Biotechnology Inc
11 Oct 19
Prospectus supplement with pricing info
5:31pm
legislation designed to, among other things, bring more transparency to drug and biological product pricing, reduce the cost of prescription drugs … , discounts, restrictions on certain product access and marketing cost disclosure and transparency measures and, in some cases, designed to encourage
10-K
2019 FY
VIR
Vir Biotechnology Inc
26 Mar 20
Annual report
4:08pm
-issued “Written Request” for such a study.
Federal and State Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations … -kickback and false claims laws and regulations, data privacy and security, and transparency laws and regulations, including, without limitation, those
DRS/A
s62cgm 7lq5
7 Aug 19
Draft registration statement (amended)
12:00am
DRS
lcwmc6bfq3vq
27 Jun 19
Draft registration statement
12:00am
S-1
66chh9p
3 Sep 19
IPO registration
4:40pm
S-1/A
o4fm4pms8m0uo6cd
30 Sep 19
IPO registration (amended)
6:12am
8-K
EX-99.2
0bcg9dakho9m7jfhf
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
10-Q
nheert0cm m4uc1t
19 Nov 19
Quarterly report
4:06pm
- Prev
- 1
- Next